期刊文献+

手术治疗非小细胞肺癌152例临床分析 被引量:4

Clinical analysis of surgical treatment of primary non-small cell lung cancer:a report of 152 cases
下载PDF
导出
摘要 目的探讨手术治疗非小细胞肺癌的效果及影响预后的因素。方法回顾性分析1990年1月至2000年1月接受手术治疗的152例非小细胞肺癌患者的临床资料,并进行随访,采用Kaplan-Meier法计算5年生存率。结果5年总体生存率为36.8%,年龄、性别及术后是否化疗与预后无关,不同病理类型、病理分期和不同手术方式的5年生存率比较差异均有统计学意义(P<0.05)。结论手术是治疗非小细胞肺癌的首选方案。病理类型、病理分期和手术方式是影响预后的主要因素。早期诊断、早期手术治疗及选择合适的手术方式可改善预后。 Objective To discuss therapeutic effect of surgery treatment of primary non-small cell lung cancer and relative factors of influencing prognosis. Methods A retrospective analysis was performed for clinical data of 152 patients with primary non-small cell lung cancer underwent operation in the fourth hospital of Jilin university between Jan. 1990 and jan. 2000 ,and follow-up was made. 5-ycar survival rate was calculated by Kaplan-Meier method. Results Overall 5-year survival rate was 36. 8%. There was no significant relationships between age, sex, postoperative chemotherapy and prognosis ( all P 〉 0. 05 ). There were significant relationships between pathological type, pathological stage, surgery mode and prognosis ( all P 〈 0. 05). Conclusions Operation is the primary treatment for non-small cell lung cancer. Pathological type, pathological stage and surgery mode are important prognostic factors for non - small cell lung cancer.
作者 南昌军 吴迪
出处 《中国厂矿医学》 CAS 2008年第2期151-152,共2页 Chinese Medicine of Factory and Mine
关键词 非小细胞肺癌 手术 预后 Non-small cell lung cancer Operation Prognosis
  • 相关文献

参考文献9

二级参考文献42

  • 1廖美琳,王恩忠.药敏试验在肺癌化疗中的指导意义[J].中华结核和呼吸杂志,1993,16(6):345-346. 被引量:4
  • 2许金良,马迎春,高宗人,卫功铨,陈明耀,程金华.原发性肺腺癌及其外科疗效(附115例报告)[J].中华胸心血管外科杂志,1995,11(6):339-341. 被引量:3
  • 3李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5Mountain CF. Revisions in the international system for staging lung cancer[J]. Chest, 1997, 111(6):1710~1717
  • 6Pfister DG, Johnson DH, Azzoli GG, et al. American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003[J].J Clin Oncol, 2004, 22(2):330~353
  • 7Carney DN, Hansen HH. Non-small-cell lung cancer-stalemate or progress [J]? N EnglJ Med, 2000, 343(17):1261~1262
  • 8Jazieh AR, Hussain M, HowingtonJA, et al. Prognostic factors in patients with surgically resected stages Ⅰ and Ⅱ non-small cell lung cancer[J]. Ann Thorac Surg, 2000, 70(4):1168~1171
  • 9Vargas SO, Leslie KO, Vacek PM, et al. Estrogen-receptor-related protein p29 in primary non-small cell lung carcinoma:pathologic and prognostic correlations [J]. Cancer, 1998, 82 (8):1495~1500
  • 10Nesbitt JC, Putnam JB, Walsh GL, et al. Survival in early-stage non-small cell lung cancer [J]. Ann Thorac Surg, 1995, 60(2):466~472

共引文献368

同被引文献22

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部